<i>LPA</i> Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins

<i>LPA</i> Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins

Coronary heart disease (CHD) is a leading cause of death globally. Although therapy with statins decreases circulating levels of low-density lipoprotein cholesterol and the incidence of CHD, additional events occur despite statin therapy in some individuals. The genetic determinants of this residual...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Wei‐Qi Wei, Xiaohui Li, QiPing Feng, Michiaki Kubo, Iftikhar J. Kullo, Peggy Peissig, Elizabeth W. Karlson, Gail P. Jarvik, Ming Ta Michael Lee, Ning Shang, Eric Larson, Todd L. Edwards, Christian M. Shaffer, Jonathan D. Mosley, Shiro Maeda, Momoko Horikoshi, Marylyn D. Ritchie, Marc S. Williams, Eric B. Larson, David R. Crosslin, Harris T. Bland, Jennifer A. Pacheco, Laura J. Rasmussen‐Torvik, David Cronkite, George Hripcsak, Nancy J. Cox, Russell A. Wilke, Christoph Stein, Jerome I. Rotter, Yukihide Momozawa, Dan M. Roden, Ronald M. Krauss, Joshua C. Denny
स्वरूप: Revisão
भाषा:अंग्रेज़ी
प्रकाशित: 2018
ऑनलाइन पहुंच:https://doi.org/10.1161/circulationaha.117.031356
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031356
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

इंटरनेट

https://doi.org/10.1161/circulationaha.117.031356
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.031356

समान संसाधन